Skip to main content

Genome-wide CRISPR activation screen identifies JADE3 as an antiviral activator of NF-kB-dependent IFITM3 expression.

Publication ,  Journal Article
Munir, M; Embry, A; Doench, JG; Heaton, NS; Wilen, CB; Orchard, RC
Published in: J Biol Chem
April 2024

The innate immune system features a web of interacting pathways that require exquisite regulation. To identify novel nodes in this immune landscape, we conducted a gain-of-function, genome-wide CRISPR activation screen with influenza A virus. We identified both appreciated and novel antiviral genes, including Jade family PHD zinc finger 3 (JADE3) a protein involved in directing the histone acetyltransferase histone acetyltransferase binding to ORC1 complex to modify chromatin and regulate transcription. JADE3 is both necessary and sufficient to restrict influenza A virus infection. Our results suggest a distinct function for JADE3 as expression of the closely related paralogs JADE1 and JADE2 does not confer resistance to influenza A virus infection. JADE3 is required for both constitutive and inducible expression of the well-characterized antiviral gene interferon-induced transmembrane protein 3 (IFITM3). Furthermore, we find JADE3 activates the NF-kB signaling pathway, which is required for the promotion of IFITM3 expression by JADE3. Therefore, we propose JADE3 activates an antiviral genetic program involving NF-kB-dependent IFITM3 expression to restrict influenza A virus infection.

Duke Scholars

Published In

J Biol Chem

DOI

EISSN

1083-351X

Publication Date

April 2024

Volume

300

Issue

4

Start / End Page

107153

Location

United States

Related Subject Headings

  • Signal Transduction
  • RNA-Binding Proteins
  • Oncogene Proteins
  • NF-kappa B
  • Membrane Proteins
  • Influenza, Human
  • Influenza A virus
  • Immunity, Innate
  • Humans
  • HEK293 Cells
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Munir, M., Embry, A., Doench, J. G., Heaton, N. S., Wilen, C. B., & Orchard, R. C. (2024). Genome-wide CRISPR activation screen identifies JADE3 as an antiviral activator of NF-kB-dependent IFITM3 expression. J Biol Chem, 300(4), 107153. https://doi.org/10.1016/j.jbc.2024.107153
Munir, Moiz, Aaron Embry, John G. Doench, Nicholas S. Heaton, Craig B. Wilen, and Robert C. Orchard. “Genome-wide CRISPR activation screen identifies JADE3 as an antiviral activator of NF-kB-dependent IFITM3 expression.J Biol Chem 300, no. 4 (April 2024): 107153. https://doi.org/10.1016/j.jbc.2024.107153.
Munir M, Embry A, Doench JG, Heaton NS, Wilen CB, Orchard RC. Genome-wide CRISPR activation screen identifies JADE3 as an antiviral activator of NF-kB-dependent IFITM3 expression. J Biol Chem. 2024 Apr;300(4):107153.
Munir, Moiz, et al. “Genome-wide CRISPR activation screen identifies JADE3 as an antiviral activator of NF-kB-dependent IFITM3 expression.J Biol Chem, vol. 300, no. 4, Apr. 2024, p. 107153. Pubmed, doi:10.1016/j.jbc.2024.107153.
Munir M, Embry A, Doench JG, Heaton NS, Wilen CB, Orchard RC. Genome-wide CRISPR activation screen identifies JADE3 as an antiviral activator of NF-kB-dependent IFITM3 expression. J Biol Chem. 2024 Apr;300(4):107153.

Published In

J Biol Chem

DOI

EISSN

1083-351X

Publication Date

April 2024

Volume

300

Issue

4

Start / End Page

107153

Location

United States

Related Subject Headings

  • Signal Transduction
  • RNA-Binding Proteins
  • Oncogene Proteins
  • NF-kappa B
  • Membrane Proteins
  • Influenza, Human
  • Influenza A virus
  • Immunity, Innate
  • Humans
  • HEK293 Cells